Literature DB >> 16441253

Complete DNA sequence variation in the apolipoprotein H (beta-glycoprotein I) gene and identification of informative SNPs.

Qi Chen1, M Ilyas Kamboh.   

Abstract

Apolipoprotein H (APOH), also known as beta2-glycoprotein I, is a major antigen for the production of antiphospholipid antibodies in autoimmune diseases. Previously we have examined DNA variation in the coding region of the APOH gene and determined the molecular basis of the common protein polymorphism. Here we report the results of DNA sequence variation in the entire APOH gene encompassing a 20.3 kb region in 46 Caucasian Americans and 48 African American chromosomes. A total of 150 single nucleotide polymorphisms (SNPs) and one tri-allelic polymorphism were identified, including 8 in the coding region, 14 in the 5'-region and 2 in the 3'- region; the remainder were observed in introns. The observed number of SNPs was higher in the African American sample than in the Caucasian sample (130 vs. 84). We examined the race-specific linkage disequilibrium pattern among SNPs and identified maximally informative SNPs for future association studies. Altogether, we have identified 17 informative SNPs among Caucasians and 35 in blacks. The discovery of a full range of sequence variation and identification of race-specific informative SNPs in the APOH gene may facilitate the rapid evaluation of this variation in relation to autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16441253     DOI: 10.1111/j.1529-8817.2005.00211.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  7 in total

1.  A unified framework for linkage and association analysis of quantitative traits.

Authors:  Josée Dupuis; David O Siegmund; Benjamin Yakir
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-11       Impact factor: 11.205

2.  Beta2-glycoprotein I gene polymorphisms Val247Leu and Trp316Ser in Spanish patients with primary antiphospholipid syndrome.

Authors:  J Pardos-Gea; J Castro-Marrero; J Cortés-Hernández; E Balada; A Pedrosa; M Vilardell-Tarrés; J Ordi-Ros
Journal:  Rheumatol Int       Date:  2011-01-15       Impact factor: 2.631

3.  Functional and genetic characterization of the promoter region of apolipoprotein H (beta2-glycoprotein I).

Authors:  Sangita Suresh; F Yesim Demirci; Iliya Lefterov; Candace M Kammerer; Rosalind Ramsey-Goldman; Susan Manzi; M Ilyas Kamboh
Journal:  FEBS J       Date:  2010-01-18       Impact factor: 5.542

4.  Comprehensive evaluation of apolipoprotein H gene (APOH) variation identifies novel associations with measures of lipid metabolism in GENOA.

Authors:  Magalie S Leduc; Lawrence C Shimmin; Kathy L E Klos; Craig Hanis; Eric Boerwinkle; James E Hixson
Journal:  J Lipid Res       Date:  2008-08-01       Impact factor: 5.922

5.  Apolipoprotein H promoter polymorphisms in relation to lupus and lupus-related phenotypes.

Authors:  Sangita Suresh; F Yesim K Demirci; Erin Jacobs; Amy H Kao; Elisa Y Rhew; Dharambir K Sanghera; Faith Selzer; Kim Sutton-Tyrrell; David McPherson; Franklin A Bontempo; Candace M Kammerer; Rosalind Ramsey-Goldman; Susan Manzi; M Ilyas Kamboh
Journal:  J Rheumatol       Date:  2009-02       Impact factor: 4.666

6.  Association of the Trp316Ser variant (rs1801690) near the apolipoprotein H (β2-glycoprotein-I) gene and serum lipid levels.

Authors:  Tao Guo; Rui-Xing Yin; Hui Li; Yi-Ming Wang; Jin-Zhen Wu; De-Zhai Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

7.  Genome-wide significant results identified for plasma apolipoprotein H levels in middle-aged and older adults.

Authors:  Karen A Mather; Anbupalam Thalamuthu; Christopher Oldmeadow; Fei Song; Nicola J Armstrong; Anne Poljak; Elizabeth G Holliday; Mark McEvoy; John B Kwok; Amelia A Assareh; Simone Reppermund; Nicole A Kochan; Teresa Lee; David Ames; Margaret J Wright; Julian N Trollor; Peter W Schofield; Henry Brodaty; Rodney J Scott; Peter R Schofield; John R Attia; Perminder S Sachdev
Journal:  Sci Rep       Date:  2016-03-31       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.